In patients with unprovoked VTE, does the addition of FDG PET/CT to a limited occult cancer screening strategy offer good value for money? A cost-effectiveness analysis from the publicly funded health care systems

  Philippe Robin ^{1, 2} AuthorId : 136396

Author

  Srishti Kumar AuthorId : 11426718
Author

  Pierre-Yves Salaun ^{1, 2} AuthorId : 700358
Author

  Pierre-Yves Le Roux ^{1, 2} AuthorId : 700361
Author

  Francis Couturaud ^{3, 2} AuthorId : 453792
Author

  Benjamin Planquette ^{4, 5, 6} AuthorId : 860642

Author

  Adel Merah AuthorId : 11420655
Author

  Pierre-Marie Roy ⁷ AuthorId : 236658
Author

  Kednapa Thavorn AuthorId : 11426719
Author

  Grégoire Le Gal ^{2, 8} AuthorId : 453319
Author